Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.

Aomar Millán, I.; Salvatierra, Juan; Torres Parejo, Úrsula; Faro-Miguez, Naya; Callejas Rubio, José Luis; Ceballos Torres, Ángel; Cruces Moreno, María Teresa; Gómez Jiménez, Francisco Javier; Hernández Quero, José; Anguita-Santos, F.

doi:10.1007/s11739-020-02600-z

ANAINRA COVID (578.6Kb)

Identificadores

URI: https://hdl.handle.net/10481/100739

DOI: 10.1007/s11739-020-02600-z

Exportar

Fecha

2021-06

Referencia bibliográfica

Aomar-Millán IF, Salvatierra J, Torres-Parejo Ú, Faro-Miguez N, Callejas-Rubio JL, Ceballos-Torres Á, Cruces-Moreno MT, Gómez-Jiménez FJ, Hernández-Quero J, Anguita-Santos F. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study. Intern Emerg Med. 2021 Jun;16(4):843-852. doi: 10.1007/s11739-020-02600-z. (IF: 3.4; Q2)

Colecciones

DMed - Artículos

Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional